Home Combat Arthritis Why Aclaris Therapeutics Stock Skyrocketed More Than 200% Today

Why Aclaris Therapeutics Stock Skyrocketed More Than 200% Today

Jan 27, 2021 comments off

Why Aclaris Therapeutics Stock Skyrocketed More Than 200% Today

Investors are excited about the biotech’s clinical trial results.

Read More…

You May Also Like

New study launches into COVID-19 vaccine responses in patients with impaired immune systems – Medical Xpress

My Flat-Footed Quest to Find the Ultimate CBD Topical

Amazon Co-Opts Crowdfunding Model to Launch "Smart" Sticky Note Printer

The Five Most Common and Serious Types of Arthritis.

Rheumatoid Arthritis Meds May Help Fight Severe COVID

"Micromotors" could more effectively treat rheumatoid arthritis